Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. (Record no. 24372529)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02323 a2200661 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517003242.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201508s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1569-8041 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1093/annonc/mdu496 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Van Cutsem, E |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150824 |
245 00 - TITLE STATEMENT | |
Title | Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Annals of oncology : official journal of the European Society for Medical Oncology |
Date of publication, distribution, etc. | Jan 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 149-156 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adenocarcinoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Capecitabine |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Deoxycytidine |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Docetaxel |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Administration Schedule |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fluorouracil |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Recurrence, Local |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Organoplatinum Compounds |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oxaliplatin |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stomach Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Taxoids |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Boni, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tabernero, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Massuti, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Middleton, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dane, F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Reichardt, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pimentel, F L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cohn, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Follana, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Clemens, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zaniboni, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Moiseyenko, V |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Harrison, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Richards, D A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Prenen, H |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pernot, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ecstein-Fraisse, E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hitier, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rougier, P |
773 0# - HOST ITEM ENTRY | |
Title | Annals of oncology : official journal of the European Society for Medical Oncology |
Related parts | vol. 26 |
-- | no. 1 |
-- | p. 149-156 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1093/annonc/mdu496">https://doi.org/10.1093/annonc/mdu496</a> |
Public note | Available from publisher's website |
No items available.